Brussels, 22 August 2024
The European Commission has approved, under the EU Merger Regulation, the acquisition of sole control of Sunrise Medical of Germany by Platinum Equity Group of the US.
The transaction relates primarily to the supply of medical aid solutions.
The Commission concluded that the notified transaction would not raise competition concerns, given that the companies are not active in the same or vertically related markets. The notified transaction was examined under the simplified merger review procedure.
More information is available on the Commission’s competition website, in the public case register under the case number M.11628.